Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alistia Ilmiah Fahira, Riezki Amalia, Melisa Intan Barliana, Vesara Ardhe Gatera & Rizky Abdulah. (2022) Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy. Breast Cancer: Targets and Therapy 14, pages 71-83.
Read now
Read now
Yuling Liu, Yingchong Chen, Longfei Lin & Hui Li. (2020) Gambogic Acid as a Candidate for Cancer Therapy: A Review. International Journal of Nanomedicine 15, pages 10385-10399.
Read now
Read now
Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Read now
Mang Mang Sang, Fu Lei Liu, Yang Wang, Ren Jie Luo, Xiao Xian Huan, Ling Fei Han, Zhong Tao Zhang, Feng Feng, Wei Qu, Wenyuan Liu & Feng Zheng. (2018) A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer. Drug Delivery 25:1, pages 1846-1857.
Read now
Read now
Articles from other publishers (34)
Ruixi He, Buyun Jia, Daiyin Peng & Weidong Chen. (2023) Caged Polyprenylated Xanthones in Garcinia hanburyi and the Biological Activities of Them. Drug Design, Development and Therapy Volume 17, pages 3625-3660.
Crossref
Crossref
Ravı KUMAR, Sunıta JHA & Akriti RAİ. (2023) Cd44 Targeted Plga Nano-Medicine For Cancer Chemotherapy- A Comprehensive Review. Journal of Immunology and Clinical Microbiology 8:3, pages 65-83.
Crossref
Crossref
Saínza Lores, Manuel Gámez-Chiachio, María Cascallar, Carmen Ramos-Nebot, Pablo Hurtado, Sandra Alijas, Rafael López López, Roberto Piñeiro, Gema Moreno-Bueno & María de la Fuente. (2023) Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment. Biomaterials Science 11:12, pages 4210-4225.
Crossref
Crossref
Usman Umar Zango, Aminu Abubakar, Rohit Saxena & Vedpriya Arya. 2023. Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer. Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer
161
181
.
Abid Naeem, Pengyi Hu, Ming Yang, Jing Zhang, Yali Liu, Weifeng Zhu & Qin Zheng. (2022) Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules 27:23, pages 8367.
Crossref
Crossref
Qing Yu, Wenzhe Wang, Haixia Ji, Luyao Tian, Mingjuan Yang, Juan Wang, Xia Li, Luqi Huang, Lanping Guo & Wenyuan Gao. (2022) Surface Membrane Coating as a Versatile Platform for Modifying Antitumor Nanoparticles. ACS Materials Letters 4:10, pages 2019-2050.
Crossref
Crossref
Vera Machado, Mariana Morais & Rui Medeiros. (2022) Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?. Pharmaceutics 14:10, pages 2092.
Crossref
Crossref
Fanghua Zhang, Chao Zhang, Shuangqing Fu, Huandi Liu, Mengnan Han, Xueyu Fan, Honglei Zhang & Wei Li. (2022) Amphiphilic Cationic Peptide-Coated PHA Nanosphere as an Efficient Vector for Multiple-Drug Delivery. Nanomaterials 12:17, pages 3024.
Crossref
Crossref
Mahsa Keihan Shokooh, Fakhrossadat Emami, Ramesh Duwa, Jee-Heon Jeong & Simmyung Yook. (2022) Triple-negative breast cancer treatment meets nanoparticles: Current status and future direction. Journal of Drug Delivery Science and Technology 71, pages 103274.
Crossref
Crossref
Daohe Wei, Han Yang, Yue Zhang, Xinhui Zhang, Jian Wang, Xiaoli Wu & Jin Chang. (2022) Nano-traditional Chinese medicine: a promising strategy and its recent advances. Journal of Materials Chemistry B 10:16, pages 2973-2994.
Crossref
Crossref
Ana Isabel Fraguas-Sánchez, Irene Lozza & Ana Isabel Torres-Suárez. (2022) Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14:5, pages 1198.
Crossref
Crossref
Farhan Mazahir, Shourya Tripathi & Awesh K. Yadav. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy
171
197
.
Md. Rizwanullah, Mohammad Zaki Ahmad, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Shadab Md, Nabil A. Alhakamy, Keerti Jain & Javed Ahmad. (2021) Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics 13:12, pages 2039.
Crossref
Crossref
Kumar Ganesan, Yan Wang, Fei Gao, Qingqing Liu, Chen Zhang, Peng Li, Jinming Zhang & Jianping Chen. (2021) Targeting Engineered Nanoparticles for Breast Cancer Therapy. Pharmaceutics 13:11, pages 1829.
Crossref
Crossref
Tresa López-Royo, Víctor Sebastián, Laura Moreno-Martínez, Laura Uson, Cristina Yus, Teresa Alejo, Pilar Zaragoza, Rosario Osta, Manuel Arruebo & Raquel Manzano. (2021) Encapsulation of Large-Size Plasmids in PLGA Nanoparticles for Gene Editing: Comparison of Three Different Synthesis Methods. Nanomaterials 11:10, pages 2723.
Crossref
Crossref
Rômulo S. Cavalcante, Uta Ishikawa, Emanuell S. Silva, Arnóbio A. Silva‐Júnior, Aurigena A. Araújo, Luis J. Cruz, Alan B. Chan & Raimundo F. de Araújo Júnior. (2021) STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer. British Journal of Pharmacology 178:11, pages 2284-2304.
Crossref
Crossref
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Crossref
Bonglee Kim, Ji-Eon Park, Eunji Im, Yongmin Cho, Jinjoo Lee, Hyo-Jung Lee, Deok-Yong Sim, Woon-Yi Park, Bum-Sang Shim & Sung-Hoon Kim. (2021) Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression. International Journal of Molecular Sciences 22:7, pages 3571.
Crossref
Crossref
Deepika Singh, Mallika Tewari, Sunita Singh & Gopeshwar Narayan. (2021) Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy. Future Oncology 17:5, pages 581-596.
Crossref
Crossref
Hiu Yee Kwan, Qinghua Xu, Ruihong Gong, Zhaoxiang Bian & Chih-Chang Chu. (2021) Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study. Frontiers in Oncology 10.
Crossref
Crossref
Long Zhang, Hongyan Xu, Xiaoxiao Wu, Wenjuan Huang, Tinghong Zhang, Pengyan Hao, Bo Peng & Xingjie Zan. (2020) A Strategy to Fight against Triple-Negative Breast Cancer: pH-Responsive Hexahistidine-Metal Assemblies with High-Payload Drugs. ACS Applied Bio Materials 3:8, pages 5331-5341.
Crossref
Crossref
Jiahuan Zhu, Fuhua Qin, Zhonghua Ji, Weidong Fei, Zeng Tan, Ying Hu & Caihong Zheng. (2019) Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis. AAPS PharmSciTech 21:1.
Crossref
Crossref
Mangmang Sang, Lingfei Han, Renjie Luo, Wei Qu, Feng Zheng, Kaigang Zhang, Fulei Liu, Jingwei Xue, Wenyuan Liu & Feng Feng. (2020) CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer. Biomaterials Science 8:1, pages 212-223.
Crossref
Crossref
Ke Song, Zhaobo Wang, Xue Liu, Guolin Zhang, Xin Wang, DeFang Ouyang, Mingrui Guo & Lijiang Chen. (2019)
A novel dual sensitive polymer-gambogic acid conjugate: synthesis, characterization, and
in vitro
evaluation
. Nanotechnology 30:50, pages 505701.
Crossref
Crossref
Hua Luo, Chi Teng Vong, Hanbin Chen, Yan Gao, Peng Lyu, Ling Qiu, Mingming Zhao, Qiao Liu, Zehua Cheng, Jian Zou, Peifen Yao, Caifang Gao, Jinchao Wei, Carolina Oi Lam Ung, Shengpeng Wang, Zhangfeng Zhong & Yitao Wang. (2019) Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chinese Medicine 14:1.
Crossref
Crossref
Richa Verma, Rajnish Sahu, Desh Deepak Singh & Timothy E. Egbo. (2019) A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections. Seminars in Cell & Developmental Biology 96, pages 44-52.
Crossref
Crossref
Hui-hai Zhong, Hui-yuan Wang, Jian Li & Yong-zhuo Huang. (2019) TRAIL-based gene delivery and therapeutic
strategies. Acta Pharmacologica Sinica 40:11, pages 1373-1385.
Crossref
Crossref
Adelijiang Wusiman, Jin He, Tianyu Zhu, Zhenguang Liu, Pengfei Gu, Yuanliang Hu, Jiaguo Liu & Deyun Wang. (2019) Macrophage immunomodulatory activity of the cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharide. International Journal of Biological Macromolecules 134, pages 730-739.
Crossref
Crossref
Joseph M. Caster, Cameron Callaghan, Steven N. Seyedin, Kelly Henderson, Bo Sun & Andrew Z. Wang. (2019) Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy. Advanced Drug Delivery Reviews 144, pages 3-15.
Crossref
Crossref
Akshayya Pawar & Priyanka Prabhu. (2019) Nanosoldiers: A promising strategy to combat triple negative breast cancer. Biomedicine & Pharmacotherapy 110, pages 319-341.
Crossref
Crossref
Ning Yin, Liu Yi, Sumbul Khalid, Ulku Ozbey, Uteuliev Yerzhan Sabitaliyevich & Ammad Ahmad Farooqi. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance
243
252
.
Mangmang Sang, Lingfei Han, Renjie Luo, Fulei Liu, Yang Wang, Wei Qu, Feng Zheng, Wenyuan Liu & Feng Feng. (2018) WITHDRAWN: Magnetic and CD44 receptor dual targeting redox-responsive polymeric micelle for precise delivery of Gambogic acid to triple-negative breast cancer. Asian Journal of Pharmaceutical Sciences.
Crossref
Crossref
Ankit Saneja, Divya Arora, Robin Kumar, Ravindra Dhar Dubey, Amulya K. Panda & Prem N. Gupta. (2018) CD44 targeted PLGA nanomedicines for cancer chemotherapy. European Journal of Pharmaceutical Sciences 121, pages 47-58.
Crossref
Crossref
Jun Li, Huamin Liang, Jing Liu & Ziyuan Wang. (2018) Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. International Journal of Pharmaceutics 546:1-2, pages 215-225.
Crossref
Crossref